HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mélanie Saint-Jean Selected Research

DNA (Deoxyribonucleic Acid)

7/2017Efficient treatment of a metastatic melanoma patient with a combination of BRAF and MEK inhibitors based on circulating tumor DNA analysis: a case report.
10/2016Clinical significance of BRAF mutation status in circulating tumor DNA of metastatic melanoma patients at baseline.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mélanie Saint-Jean Research Topics

Disease

16Melanoma (Melanoma, Malignant)
02/2024 - 11/2011
5Acne Vulgaris
03/2018 - 01/2015
4Neoplasms (Cancer)
04/2018 - 01/2012
2Skin Neoplasms (Skin Cancer)
12/2023 - 07/2023
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2023 - 12/2017
2Basal Cell Carcinoma (Rodent Ulcer)
10/2016 - 04/2016
2Weight Loss (Weight Reduction)
04/2016 - 11/2013
1Cytokine Release Syndrome
01/2023
1Drug Hypersensitivity Syndrome
02/2019
1Darier Disease (Darier's Disease)
01/2019
1Pyoderma Gangrenosum
04/2018
1Inflammation (Inflammations)
03/2018
1Neoplasm Metastasis (Metastasis)
01/2018
1Bowen's Disease (Disease, Bowen)
12/2017
1Actinic Keratosis
12/2017
1Hemangiosarcoma (Angiosarcoma)
11/2016
1Dysgeusia (Parageusia)
04/2016
1Cicatrix (Scar)
01/2016
1Phototoxic Dermatitis (Phototoxicity)
09/2015
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2015
1Mycosis Fungoides
12/2013
1Anorexia
11/2013
1Radiodermatitis
11/2013
1Vascular Skin Diseases
07/2013
1Hemangioma (Angioma)
05/2011

Drug/Important Bio-Agent (IBA)

4VemurafenibIBA
02/2019 - 11/2013
3Interleukin-2 (IL2)IBA
01/2018 - 01/2012
2NivolumabIBA
02/2024 - 04/2018
2Immune Checkpoint InhibitorsIBA
07/2023 - 07/2020
2Fluorouracil (Carac)FDA LinkGeneric
01/2019 - 12/2017
2dabrafenibIBA
04/2018 - 09/2015
2Biomarkers (Surrogate Marker)IBA
04/2018 - 01/2012
2Circulating Tumor DNAIBA
07/2017 - 10/2016
2DNA (Deoxyribonucleic Acid)IBA
07/2017 - 10/2016
2Propranolol (Inderal)FDA LinkGeneric
11/2016 - 05/2011
2HhAntag691IBA
10/2016 - 04/2016
2Proteins (Proteins, Gene)FDA Link
01/2016 - 11/2011
1IpilimumabIBA
02/2024
1cemiplimabIBA
01/2023
1Monoclonal AntibodiesIBA
01/2023
1cobimetinibIBA
02/2019
1AlitretinoinFDA Link
01/2019
1trametinibIBA
04/2018
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
04/2018
1Programmed Cell Death 1 ReceptorIBA
04/2018
1Keratins (Keratin)IBA
03/2018
1Isotretinoin (Accutane)FDA LinkGeneric
08/2017
1Spironolactone (Aldactone)FDA LinkGeneric
08/2017
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
07/2017
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
04/2017
1Niacinamide (Nicotinamide)FDA LinkGeneric
04/2017
1piroctone olamineIBA
04/2017
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2016
1Interleukin-10 (Interleukin 10)IBA
01/2016
1Tissue Inhibitor of Metalloproteinase-2IBA
01/2016
1Testosterone (Sustanon)FDA Link
01/2015
1VorinostatFDA Link
01/2015
1Aminolevulinic Acid (Levulan)FDA Link
12/2013
11-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2013
1Lapatinib (GW572016)FDA Link
07/2013
1Interleukin-2 Receptors (IL 2 Receptor)IBA
01/2012
1Transcription Factors (Transcription Factor)IBA
01/2012
1CD58 Antigens (LFA-3)IBA
01/2012
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2012
1Messenger RNA (mRNA)IBA
11/2011

Therapy/Procedure

5Therapeutics
12/2023 - 01/2012
2Immunotherapy
07/2020 - 01/2018
1Drug Therapy (Chemotherapy)
07/2020
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2018
1Aftercare (After-Treatment)
12/2017
1Transplantation
04/2017
1Photochemotherapy (Photodynamic Therapy)
12/2013